Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Emmessar Biotech And NutritionBOM:524768 +0.25%51 Days Inventory is 25.77 as of Jun. 2026, which is 87% below its 10-year median of 202.22. GuruFocus rates BOM:524768 with a GF Score™ of 51/100 and a GF Value™ of ₹18.24 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 921 Drug Manufacturers companies, Emmessar Biotech And Nutrition ranks worse than 91.75% on this metric.
The historical rank and industry rank for Emmessar Biotech And Nutrition's Days Inventory or its related term are showing as below:
BOM:524768'
s Days Inventory Range Over the Past 10 Years
Min: 62.85 Med: 202.22 Max: 1198.53
Current: 367.1
During the past 13 years, Emmessar Biotech And Nutrition's highest Days Inventory was 1198.53. The lowest was 62.85. And the median was 202.22.
BOM:524768's Days Inventory is ranked worse than 91.75% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.34
vs BOM:524768: 367.10
Inventory Turnover measures how fast the company turns over its inventory within a year.
Emmessar Biotech And Nutrition's Inventory Turnover for the
three
months ended in Jun. 2026 was 3.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Emmessar Biotech And Nutrition's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 1.64.
Emmessar Biotech And Nutrition (BOM:524768) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Emmessar Biotech And Nutrition's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Emmessar Biotech And Nutrition's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Emmessar Biotech And Nutrition Days Inventory Related Terms
Emmessar Biotech And Nutrition Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emmessar Biotech And Nutrition Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Emmessar Biotech And Nutrition's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emmessar Biotech And Nutrition Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Emmessar Biotech And Nutrition's Days Inventory distribution charts can be found below:
* The bar in red indicates where Emmessar Biotech And Nutrition's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Emmessar Biotech And Nutrition (BOM:524768) has a Days Inventory of 25.77 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Emmessar Biotech And Nutrition and its competitors. This is 87% below median its historical median of 202.22. Over the past decade, Emmessar Biotech And Nutrition's Days Inventory has ranged from 62.85 to 1,198.53. According to the industry distribution chart, Emmessar Biotech And Nutrition ranks #845 out of 921 companies in the Drug Manufacturers industry, placing it in the top 91.7%.
Is Emmessar Biotech And Nutrition's Days Inventory too high?
Emmessar Biotech And Nutrition's current Days Inventory of 25.77 is 87% below median its 10-year median of 202.22. Over the past 10 years, this metric has ranged from a low of 62.85 to a high of 1,198.53. The Drug Manufacturers industry median Days Inventory is 165.34. Emmessar Biotech And Nutrition's value of 25.77 is 84.4% below this industry median. Based on the distribution chart, Emmessar Biotech And Nutrition ranks #845 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Emmessar Biotech And Nutrition has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Emmessar Biotech And Nutrition's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Emmessar Biotech And Nutrition ranks #845 out of 921 companies for Days Inventory. This places Emmessar Biotech And Nutrition in the lower half of its industry. The industry median Days Inventory is 165.34. Emmessar Biotech And Nutrition's value of 25.77 is 84.4% below this benchmark. Historically, Emmessar Biotech And Nutrition's own Days Inventory has ranged from 62.85 to 1,198.53 over the past decade. While the company's 10-year median is 202.22 vs. the industry median of 165.34, Emmessar Biotech And Nutrition has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.34, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Emmessar Biotech And Nutrition's current Days Inventory of 25.77 is 84.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Emmessar Biotech And Nutrition and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Emmessar Biotech And Nutrition's current Days Inventory is 25.77, which is 87% below median its own 10-year median of 202.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emmessar Biotech And Nutrition stock overvalued right now?
Based on GuruFocus' analysis, Emmessar Biotech And Nutrition (BOM:524768) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹18.24, compared to a current price of ₹24.06 — trading 31.9% above its estimated fair value. The current Days Inventory is 25.77, which is 87% below median its 10-year median of 202.22 and 84.4% below the Drug Manufacturers industry median of 165.34. Emmessar Biotech And Nutrition's overall GF Score™ is 51/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Emmessar Biotech And Nutrition (BOM:524768), the current Days Inventory is 25.77 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Emmessar Biotech And Nutrition (BOM:524768) Overvalued in 2026?
Based on GuruFocus' analysis, Emmessar Biotech And Nutrition stock appears to be overvalued.
The current stock price of ₹24.06 is trading 31.9% above its estimated GF Value™ of ₹18.24.
GuruFocus considers Emmessar Biotech And Nutrition to be Significantly Overvalued.
Key valuation signals for BOM:524768:
Days Inventory: 25.77 (87% below median its 10-year median of 202.22)
GF Value™: ₹18.24 vs. price of ₹24.06 (31.9% above fair value)
Industry Position: 84.4% below the Drug Manufacturers median (#845 of 921)
No single metric tells the full story. See the BOM:524768 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.
51GF Score
Get the complete analysis for BOM:524768
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524768 has been successfully added to your 
